MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas

MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas

Improved biomarkers are needed for vestibular schwannoma (VS), the most common tumor of the cerebellopontine angle, as existing clinical biomarkers have poor predictive value. Factors such as tumor size or growth rate do not shed light on the pathophysiology of associated sensorineural hearing loss...

Full description

Bibliographic Details
Main Authors: Yin Ren, Hiroshi Hyakusoku, Jessica E. Sagers, Lukas D. Landegger, D. Bradley Welling, Konstantina M. Stankovic
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Cellular Neuroscience
Subjects:
MMP-14
vestibular schwannoma
biomarker
hearing loss
surgical outcome
Online Access:https://www.frontiersin.org/article/10.3389/fncel.2020.00191/full

Internet

https://www.frontiersin.org/article/10.3389/fncel.2020.00191/full

Similar Items